Loading...
XKRX
033270
Market cap164mUSD
Jul 10, Last price  
17,730.00KRW
1D
3.32%
1Q
-12.87%
Jan 2017
-4.16%
IPO
337.36%
Name

Korea United Pharm Inc

Chart & Performance

D1W1MN
XKRX:033270 chart
P/E
6.68
P/S
0.89
EPS
2,652.61
Div Yield, %
2.62%
Shrs. gr., 5y
1.87%
Rev. gr., 5y
5.98%
Revenues
288.76b
+0.02%
67,591,173,00059,695,984,00094,700,346,000119,084,235,000134,958,313,000145,453,052,970134,829,851,010136,891,130,450155,189,552,760162,045,984,970176,905,089,970197,023,264,150211,935,529,520221,310,874,550215,949,552,650221,039,962,910262,522,022,550278,943,296,810288,706,730,000288,764,868,000
Net income
38.31b
+18.04%
3,950,757,0005,575,526,0008,874,396,00014,199,566,00016,843,455,00020,208,058,00016,378,830,02012,212,392,03018,374,835,73021,721,432,86019,513,764,60027,863,650,61031,672,447,39030,915,946,39026,613,256,99028,648,749,06045,275,093,91048,261,713,56032,452,988,00038,308,011,000
CFO
51.14b
+90.86%
9,748,487,0003,403,072,0007,052,230,00018,592,288,00016,513,470,00027,617,981,46022,221,118,10018,968,292,20021,314,121,92025,958,328,35030,021,142,51027,682,926,11036,862,476,78038,154,022,07036,962,044,55044,085,211,25063,782,033,40050,648,511,71926,794,034,00051,139,053,000
Dividend
Dec 29, 2025450 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Korea United Pharm Inc. is a South Korean enterprise dedicated to the development, production, and distribution of a wide array of pharmaceutical products. The company's extensive portfolio encompasses therapeutic solutions for various medical fields, such as the respiratory, musculoskeletal, gastrointestinal, cardiovascular, and central nervous systems, in addition to treatments for cancer, infections, allergies, and immune disorders. It also supplies over-the-counter drugs. While deeply rooted in the South Korean market, the firm extends its reach internationally, exporting its medications to nearly 40 countries. Founded in 1987, Korea United Pharm Inc. is headquartered in Seoul, South Korea.
IPO date
Oct 23, 2007
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT